Latest Conference Articles

To Help Reduce the Burden of Chronic Liver Disease, Primary Care Needs Simple, Reliable, Available Tools

To Help Reduce the Burden of Chronic Liver Disease, Primary Care Needs Simple, Reliable, Available Tools

December 4th 2023

AASLD The Liver Meeting

Transplant hepatologist Dr Bruce Luxon says primary care is essential to making progress against chronic liver disease but doesn't have the resources it needs.

10 Top Studies from The Liver Meeting 2023: At-a-Glance

10 Top Studies from The Liver Meeting 2023: At-a-Glance

December 1st 2023

AASLD The Liver Meeting

Simplified risk stratification tools for NAFLD, effects of statins on hepatic disease, trends in OHE, and patient perspectives are samples of the noteworthy research areas.

Underestimation of OHE Hospitalizations: Author of New Study Discusses Clinical Implications, Takeaways for Primary Care Clinicians

Underestimation of OHE Hospitalizations: Author of New Study Discusses Clinical Implications, Takeaways for Primary Care Clinicians

November 29th 2023

AASLD The Liver Meeting

Arun Jesudian, MD, details key findings from a study he recently presented at The Liver Meeting 2023.

Cutting Daily Sodium Intake Significantly Lowers Blood Pressure in 1 Week, According to New Research

Cutting Daily Sodium Intake Significantly Lowers Blood Pressure in 1 Week, According to New Research

November 15th 2023

American Heart Association

AHA 2023: Reducing daily sodium intake by about 4000 mg significantly lowered SBP in approximately 73% of adults in 1 week when compared to a higher sodium diet.

Systolic BP Target of <120 mm Hg Reduces CV Event Risk, According to New Data from AHA Scientific Sessions 2023

Systolic BP Target of <120 mm Hg Reduces CV Event Risk, According to New Data from AHA Scientific Sessions 2023

November 14th 2023

American Heart Association

AHA 2023: An intensive 3-year treatment targeting SPB <120 mm Hg resulted in 39% lower CV mortality than standard treatment in patients with HTN at high risk of CVD.

Speech May be a Promising Biomarker for MHE, OHE, According to New Research

Speech May be a Promising Biomarker for MHE, OHE, According to New Research

November 13th 2023

AASLD The Liver Meeting

TLM 2023: Speech analyzed from a smartphone app recording identified MHE and predicted OHE with results comparable to those from validated assessments.

How to Change the Course of Chronic Liver Disease in the US: Create a Groundswell Movement

How to Change the Course of Chronic Liver Disease in the US: Create a Groundswell Movement

November 13th 2023

AASLD The Liver Meeting

TLM 2023: Reduce disease stigma and treatment inequality, build awareness for early diagnosis across specialties, support clinicians with accessible tools, and that's a start.

NASH Diagnosis: Patients Overwhelmed But Motivated to Adhere to Guidance and Want More Help, Survey Finds

NASH Diagnosis: Patients Overwhelmed But Motivated to Adhere to Guidance and Want More Help, Survey Finds

November 12th 2023

AASLD The Liver Meeting

More education that is clear and from reliable sources is needed for patients with a NASH diagnosis and their caregivers throughout the duration of the disease.

Cloud-Based "Liver Toolkit" Identifies Primary Care Patients at High Risk for Fibrosis, Requiring Referral

Cloud-Based "Liver Toolkit" Identifies Primary Care Patients at High Risk for Fibrosis, Requiring Referral

November 11th 2023

AASLD The Liver Meeting

One in 5 patients identified as at risk for advanced chronic liver disease had advanced fibrosis and PCP was prompted to refer to hepatology.

FIB-4 Risk-Stratification Algorithm for MASLD Improved Primary Care Practice Patterns, According to New Research

FIB-4 Risk-Stratification Algorithm for MASLD Improved Primary Care Practice Patterns, According to New Research

November 10th 2023

AASLD The Liver Meeting

TLM 2023: Primary care clinicians exposed to a FIB4-based risk stratification algorithm reported applying it routinely for patients with elevated LFTs after the introduction.